Pretreatment HDL‐C and ApoA1 are predictive biomarkers of progression‐free survival in patients with EGFR mutated advanced non‐small cell lung cancer treated with TKI

Abstract Background We aimed to explore the correlation between blood lipids (high density lipoprotein cholesterol [HDL‐C] and apolipoprotein A1 [ApoA1]) and epidermal growth factor receptor (EGFR) T790M mutation, as well as its predictive role in clinical efficacy and progression‐free survial (PFS)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Juan Ma, Ying Bai, Mei Liu, Tong Jiao, Yang Chen, Bo Yuan, Boxuan Liu, Lizhong Zeng, Zongjuan Ming, Wei Li, Ruiying Sun, Xia Yang, Shuanying Yang
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2022-04-01
Colecção:Thoracic Cancer
Assuntos:
advanced non‐small cell lung cancer
apolipoprotein A1
epidermal growth factor receptor
high density lipoprotein cholesterol
progression‐free survival
Acesso em linha:https://doi.org/10.1111/1759-7714.14367
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados